These days, large language models are pushing the line between schizophrenic break and reality closer than ever before.

In a wild new post that’s going viral on X-formerly-Twitter, an enterprising young biochemist named Douglas Yao showcased a new drug he’s been developing with the aid of ChatGPT. He’s not employed by any pharma company, and his drug lab is setup on a couple folding tables in his garage.

Specifically, Yao enthuses about a new drug he calls “PAC-3310,” which he says is meant to treat schizophrenia. “It was designed by ChatGPT,” Yao explains, “and I synthesized it in a chemistry lab I built in my garage.”

The result is a small vial of yellow powder — the first sample of 3310, apparently — which Yao says is modeled after the recently-authorized antipsychotic Cobenfy, “but improved.”

This vial contains a new drug called PAC-3310. It was designed by ChatGPT, and I synthesized it in a chemistry lab I built in my garage.

PAC-3310 is a new selective M4 muscarinic receptor agonist for treating schizophrenia – similar to the recent breakthrough drug Cobenfry, but… pic.twitter.com/o7z6iLR50T

— Douglas Yao (@DouglasYaoDY) September 8, 2026

On his GitHub page, Yao boasts that he’s used AI to “design several thousand new small molecule drugs” over the past year, including a “new Alzheimer’s drug,” which he’s developing in addition to the schizophrenia treatment.

“I then taught myself synthetic chemistry, built a chem lab in my garage, and synthesized a hundred of them,” he continued. “I’m now testing these compounds in cell lines and mice.”

But whatever the one-man pharma lab hopes to accomplish is difficult to say. Yao references the fact that “drug developers typically spend tens of millions of dollars generating pre-clinical efficacy evidence for a new drug,” saying that “my approach can do this at 1/1000 the cost.” This seems to suggest dreams of someday manufacturing the various drugs on a massive scale for human consumption — a process that would take years of grueling and expensive work for a well-resourced drug lab, let alone a solo entrepreneur using a box fan as a fume hood.

For instance, to even approach the Food and Drug Administration’s “New Drug Application” — itself a costly 12-month process requiring inspection of the facility where the drug will be manufactured — one first has to conduct rounds of preclinical testing followed by three phases of clinical trials. Forget “tens of millions,” as Yao mentions; this is a process that can easily cost several billion.

Even then success is far from guaranteed, as only 13.8 percent of drugs that enter clinical trials go on to obtain full approval from the FDA.

While Yao might have been right at home in the free-wheeling research landscape of the 1970s, we no longer live in a world where a mad genius can synthesize hundreds of new drugs a year from a private lab. For one thing, the regulatory environment is much more demanding, as outlined above, to say nothing of the fact that all the low-hanging fruit has been picked from the vine decades ago.

When it comes to Yao’s ChatGPT-generated Alzheimer’s treatment, the landscape is particularly fraught. As one 2019 study found, no new drug has been approved to treat Alzheimer’s since 2003, and not for a lack of trying: as the study notes, over 200 proposed substances meant to treat the disease have either failed in clinical trials or been abandoned by their creators.

The graveyard of failed Alzheimer’s treatments is so vast that the renowned organic chemist Derek Lowe has built a blog on drug discovery which routinely features after-action reports on failed substances designed to treat the neurodegenerative disease. Simply put, to think that ChatGPT alone is enough to overcome these scientific and institutional hurdles is delusional.

Replies to Yao’s post were quick to point out the irony here, of using ChatGPT — which is well-known for leading vulnerable users down dangerous breaks from reality — to synthesize drugs to treat cognitive diseases like Alzheimer’s and schizophrenia.

“Hello schizophrenic, take this medicine that chatgpt made for you,” one poster quipped on X.

Another replied that “believing you single-handedly cured schizophrenia on a commercial laundry folding table in a garage is, ironically, a classic symptom of schizophrenia.”

More on ChatGPT: Man Obliterated When Court Obtains His ChatGPT Transcripts

The post Man Announces That He Has Synthesized a New Schizophrenia Treatment in His Garage, Based on a Formula Devised by ChatGPT appeared first on Futurism.

For over two decades, a notorious fugitive accused of horrible crimes in Rhode Island hid out in one of the places you’d most expect — the corner office of a Big Pharma company.

Reported by Stat News, a 70-year old chief medical officer at the California-based firm Immix Biopharma was found to be afugitive sex predator who disappeared during his 2005 trial. Though he went by Richard Graydon in the more than twenty years since, his real name turns out to be Ronald Fischer — an anesthesiologist accused of raping numerous women on his various yachts (yes, plural).

“Although I believe my trial has gone very well and expect to be acquitted and dismissed, the small chance of losing could carry extremely and unacceptably harsh penalties,” Fischer told his lawyer via email before fleeing in 2005. “I have therefore decided not to take the risk and leave the US and enjoy life in another country where I have long been carefully planning a good, safe, secure and comfortable life.”

As it happens, Fischer never left for another country — at least not for good — but restarted his medical career in the US, leading him to rack up a number of aliases. Refusing to abandon his yachts or the medical career that paid for them, Fischer reportedly worked his way through a number of biotech companies, like Atossa Therapeutics, which appointed him interim chief medical officer in 2022.

After being hired by Immix in March of 2026, Fischer was arrested after US Marshals boarded his 56-foot vessel, The Silver Lining, as it sailed down New York’s East River. While it remains to be seen how he evaded authorities for so long, if there’s any real silver lining, it’s that this horrible fugitive is no longer lurking around the Biotech sector, or society at large.

More on crime: Innocent Man Freed After Spending Over 50 Days in Jail Due to Horribly Inaccurate AI Facial Recognition Tech

The post Man Accused of Horrific Crimes Caught Hiding as Pharma Executive appeared first on Futurism.

Since riding Donald Trump’s coattails to power, Robert F. Kennedy Jr has taken his haphazard anti-vaccine views and enshrined them as a core tenet of US health policy.

According to 16 current and former health officials who spoke to Reuters, RFK Jr has taken much more drastic measures to push his anti-vaccine agenda than was previously known.

Speaking on condition of anonymity, two officials told the news agency that RFK approached National Institute of Health director Jay Bhattacharya earlier this year with a proposal to spend up to $5 billion in tax dollars to establish links between vaccines and autism.

As Reuters notes, that kind of spending would encompass ten percent of the NIH’s annual budget, a massive waste that would fly in the face of decades of established science showing vaccines definitively don’t cause autism.

“He’s an anti-vaccine activist. That’s who he is. That’s who he’s been for 20 years,” Paul Offit, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia told Reuters. “To expect that as secretary of Health and Human Services he’d be anything other than that is wishful thinking.”

It certainly wouldn’t have been the first time RFK Jr attempted to twist the science to link vaccines with autism. Earlier this year, the US Department of Health and Human Services was caught spending $1.6 million funding a study on hepatitis B vaccines conducted by controversial Danish researchers Peter Aaby and Christine Stabell Benn.

Had the Africa Centres for Disease Control and Prevention — the public health arm of the Africa Union — not stepped in to stop the RFK-backed study, researchers would have withheld inoculations from thousands of newborn infants in Guinea-Bissau.

The situation drew notable comparisons to the Tuskegee Experiment, a highly unethical medical experiment that used hundreds of Black men as guinea pigs to study the long-term effects of syphilis. Despite the fact that effective treatment was available, nearly 400 men spent decades without treatment, suffering life-long consequences at the hands of manipulative researchers.

Though the Tuskegee Experiment may not have produced any medical breakthroughs or scientific discoveries, its cruel legacy seemingly lives on as inspiration for RFK and his HHS cronies.

More on RFK Jr: CDC Report on Vaccines and Autism Caught Citing Hallucinated Study That Does Not Exist

The post RFK Jr Wants to Waste $5 Billion in the Worst Way Imaginable appeared first on Futurism.